Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06835920 · ClinicalTrials.gov registry record · NA

Alcohol Labeling Study

A NA study of Health Behavior, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
720
Enrollment target
2
Study locations

NCT06835920 is a NA study of Health Behavior that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 720 participants, below the 2,175-participant average among 65 other Health Behavior trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06835920, a NA study of Health Behavior, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
720 participants
Enrollment target
2
Study locations

Study Summary

This study aims to examine the effects of new front-of-package alcohol warnings on alcohol consumption. Participants will be randomly assigned to either new front-of-package health warnings or control labels. Participants will bring in their own alcohol to weekly study visits and take home the alcohol to consume as usual. Participants will receive study labels on their alcohol containers per their assigned trial arm.

Conditions Studied

Interventions

  • BEHAVIORAL Control label
  • BEHAVIORAL Front-of-package health warning

Study Locations (2)

North Carolina

  • UNC study office - Chapel Hill
  • University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 720 participants
Start Date 2025-04-28
Est. Completion 2026-08
Phase NA

What the Registry Record Tells You About NCT06835920

The ClinicalTrials.gov registry entry for NCT06835920 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,175-participant average among 65 other Health Behavior trials with a reported enrollment target (67% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which Control label is the first listed.

NCT06835920 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06835920 about?

NCT06835920 is a clinical study titled "Alcohol Labeling Study". This study aims to examine the effects of new front-of-package alcohol warnings on alcohol consumption. Participants will be randomly assigned to either new front-of-package health warnings or control labels. Participants will bring in their own alcohol to weekly study visits and take home the alcoh...

What is the current status of trial NCT06835920?

This trial is currently recruiting. It is a NA study. The enrollment target is 720 participants. The study started on 2025-04-28. Estimated completion is 2026-08.

What conditions does trial NCT06835920 study?

This clinical trial studies the following conditions: Health Behavior.

What interventions are being tested in trial NCT06835920?

The interventions under investigation include: Control label (BEHAVIORAL), Front-of-package health warning (BEHAVIORAL).

Who is sponsoring clinical trial NCT06835920?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06835920 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.